Kazia Therapeutics Ltd (KZIA)
0.277
-0.01
(-1.95%)
USD |
NASDAQ |
May 03, 16:00
0.277
0.00 (0.00%)
After-Hours: 20:00
Kazia Therapeutics Enterprise Value: 5.265M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.265M |
| May 01, 2024 | 5.692M |
| April 30, 2024 | 6.643M |
| April 29, 2024 | 7.176M |
| April 26, 2024 | 7.571M |
| April 25, 2024 | 7.57M |
| April 24, 2024 | 8.072M |
| April 23, 2024 | 8.230M |
| April 22, 2024 | 7.756M |
| April 19, 2024 | 7.730M |
| April 18, 2024 | 6.944M |
| April 17, 2024 | 6.891M |
| April 16, 2024 | 5.489M |
| April 15, 2024 | 5.911M |
| April 12, 2024 | 7.202M |
| April 11, 2024 | 7.308M |
| April 10, 2024 | 9.071M |
| April 09, 2024 | 9.918M |
| April 08, 2024 | 8.494M |
| April 05, 2024 | 7.407M |
| April 04, 2024 | 6.601M |
| April 03, 2024 | 6.696M |
| April 02, 2024 | 6.498M |
| April 01, 2024 | 6.385M |
| March 28, 2024 | 5.984M |
| Date | Value |
|---|---|
| March 27, 2024 | 6.087M |
| March 26, 2024 | 6.137M |
| March 25, 2024 | 4.882M |
| March 22, 2024 | 4.933M |
| March 21, 2024 | 4.519M |
| March 20, 2024 | 5.172M |
| March 19, 2024 | 4.537M |
| March 18, 2024 | 3.947M |
| March 15, 2024 | 3.720M |
| March 14, 2024 | 3.707M |
| March 13, 2024 | 3.728M |
| March 12, 2024 | 3.272M |
| March 11, 2024 | 3.124M |
| March 08, 2024 | 3.290M |
| March 07, 2024 | 3.614M |
| March 06, 2024 | 3.509M |
| March 05, 2024 | 3.617M |
| March 04, 2024 | 4.382M |
| March 01, 2024 | 4.590M |
| February 29, 2024 | 4.542M |
| February 28, 2024 | 4.672M |
| February 27, 2024 | 5.172M |
| February 26, 2024 | 5.642M |
| February 23, 2024 | 5.937M |
| February 22, 2024 | 5.713M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.429M
Minimum
Dec 28 2022
171.31M
Maximum
Apr 08 2021
47.32M
Average
22.93M
Median
May 18 2023
Enterprise Value Benchmarks
| Immutep Ltd | -- |
| Opthea Ltd | 118.00M |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -- |
| Immuron Ltd | 3.279M |
Enterprise Value Related Metrics
| Earnings Yield | -132.4% |
| Normalized Earnings Yield | -371.90 |